Peripheral biomarkers of treatment-resistant schizophrenia: Genetic, inflammation and stress perspectives
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Peripheral biomarkers of treatment-resistant schizophrenia: Genetic, inflammation and stress perspectives
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-10-12
DOI
10.3389/fphar.2022.1005702
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants With Treatment Resistance in Schizophrenia
- (2022) Antonio F. Pardiñas et al. JAMA Psychiatry
- Reduced erythrocyte membrane polyunsaturated fatty acid levels indicate diminished treatment response in patients with multi- versus first-episode schizophrenia
- (2022) Nana Li et al. npj Schizophrenia
- Diminished treatment response in relapsed versus first-episode schizophrenia as revealed by a panel of blood-based biomarkers: A combined cross-sectional and longitudinal study
- (2022) Hualin Cai et al. PSYCHIATRY RESEARCH
- Neuroimaging Biomarkers in Schizophrenia
- (2021) Nina V. Kraguljac et al. AMERICAN JOURNAL OF PSYCHIATRY
- Genetic architecture of schizophrenia: a review of major advancements
- (2021) Sophie E. Legge et al. PSYCHOLOGICAL MEDICINE
- DNA methylation meta-analysis reveals cellular alterations in psychosis and markers of treatment-resistant schizophrenia
- (2021) Eilis Hannon et al. eLife
- Vitamin B6 deficiency hyperactivates the noradrenergic system, leading to social deficits and cognitive impairment
- (2021) Kazuya Toriumi et al. Translational Psychiatry
- Serum level of high sensitive C-reactive protein and IL − 6 markers in patients with treatment-resistant schizophrenia in Ethiopia: a comparative study
- (2021) Feyissa Challa et al. BMC Psychiatry
- Interacting Roles of COMT and GAD1 Genes in Patients with Treatment-Resistant Schizophrenia: a Genetic Association Study of Schizophrenia Patients and Healthy Controls
- (2021) Masanobu Kogure et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Treatment resistance in psychiatry: state of the art and new directions
- (2021) Oliver D. Howes et al. MOLECULAR PSYCHIATRY
- Clozapine: Why Is It So Uniquely Effective in the Treatment of a Range of Neuropsychiatric Disorders?
- (2021) Dara Gammon et al. Biomolecules
- A preliminary genetic association study of GAD1 and GABAB receptor genes in patients with treatment-resistant schizophrenia
- (2021) Atsuhiro Miyazawa et al. MOLECULAR BIOLOGY REPORTS
- Complete blood count inflammatory markers in treatment-resistant schizophrenia: Evidence of association between treatment responsiveness and levels of inflammation
- (2021) Caleb Labonté et al. PSYCHIATRY RESEARCH
- Pimavanserin augments the efficacy of atypical antipsychotic drugs in a mouse model of treatment-refractory negative symptoms of schizophrenia
- (2021) L. Rajagopal et al. BEHAVIOURAL BRAIN RESEARCH
- Effects of inflammation on the kynurenine pathway in schizophrenia — a systematic review
- (2020) Bruno Pedraz-Petrozzi et al. Journal of Neuroinflammation
- Binding of clozapine to the GABAB receptor: clinical and structural insights
- (2020) Pramod C. Nair et al. MOLECULAR PSYCHIATRY
- Serum Metabolomic Profiling Based on Fourier Transform-Ion Cyclotron Resonance-Mass Spectrometry: Do the Dysfunctions of Metabolic Pathways Reveal a Universal Risk of Oxidative Stress in Schizophrenia?
- (2020) Gaoping Cui et al. ANTIOXIDANTS & REDOX SIGNALING
- Investigating aberrantly expressed microRNAs in peripheral blood mononuclear cells from patients with treatment‑resistant schizophrenia using miRNA sequencing and integrated bioinformatics
- (2020) Xu You et al. Molecular Medicine Reports
- Telomere attrition and inflammatory load in severe psychiatric disorders and in response to psychotropic medications
- (2020) Alessio Squassina et al. NEUROPSYCHOPHARMACOLOGY
- Dopamine and Glutamate in Antipsychotic-Responsive Compared With Antipsychotic-Nonresponsive Psychosis: A Multicenter Positron Emission Tomography and Magnetic Resonance Spectroscopy Study (STRATA)
- (2020) Alice Egerton et al. SCHIZOPHRENIA BULLETIN
- High Mobility Group Protein 1 and Dickkopf-Related Protein 1 in Schizophrenia and Treatment-Resistant Schizophrenia: Associations With Interleukin-6, Symptom Domains, and Neurocognitive Impairments
- (2020) Arafat Hussein Al-Dujaili et al. SCHIZOPHRENIA BULLETIN
- Enhanced carbonyl stress and disrupted white matter integrity in schizophrenia
- (2020) Shuraku Son et al. SCHIZOPHRENIA RESEARCH
- Clozapine Response in Schizophrenia and Hematological Changes
- (2020) Graham Blackman et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Glutamate Hypothesis in Schizophrenia
- (2019) Yota Uno et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Candidate metabolic biomarkers for schizophrenia in CNS and periphery: Do any possible associations exist?
- (2019) Ting Cao et al. SCHIZOPHRENIA RESEARCH
- Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates
- (2019) Antonio Vita et al. Frontiers in Pharmacology
- Treatment-Resistant Schizophrenia: Insights From Genetic Studies and Machine Learning Approaches
- (2019) Claudia Pisanu et al. Frontiers in Pharmacology
- Clinical and Genetic Factors Associated with Resistance to Treatment in Patients with Schizophrenia: A Case-Control Study
- (2019) Aline Hajj et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Role of Aberrations in the Immune-Inflammatory Response System (IRS) and the Compensatory Immune-Regulatory Reflex System (CIRS) in Different Phenotypes of Schizophrenia: the IRS-CIRS Theory of Schizophrenia
- (2019) Chutima Roomruangwong et al. MOLECULAR NEUROBIOLOGY
- Functional neuroimaging in treatment resistant schizophrenia: A systematic review
- (2019) Cinzia Molent et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Translating preclinical findings in clinically relevant new antipsychotic targets: focus on the glutamatergic postsynaptic density. Implications for treatment resistant schizophrenia
- (2019) Andrea de Bartolomeis et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Treatment response after 6 and 26 weeks is related to baseline glutamate and GABA levels in antipsychotic-naïve patients with psychosis
- (2019) Kirsten B. Bojesen et al. PSYCHOLOGICAL MEDICINE
- Clinical Course, Neurobiology and Therapeutic Approaches to Treatment Resistant Schizophrenia. Toward an Integrated View
- (2019) Cheryl Cheuk-Yan Leung et al. Frontiers in Psychiatry
- Schizophrenia
- (2019) Stephen R. Marder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Copy Number Variation of Satellite III (1q12) in Patients With Schizophrenia
- (2019) Elizaveta S. Ershova et al. Frontiers in Genetics
- The clozapine to norclozapine ratio: a narrative review of the clinical utility to minimize metabolic risk and enhance clozapine efficacy
- (2019) Kenya A. Costa-Dookhan et al. Expert Opinion On Drug Safety
- Levels of glutamatergic neurometabolites in patients with severe treatment-resistant schizophrenia: a proton magnetic resonance spectroscopy study
- (2019) Ryosuke Tarumi et al. NEUROPSYCHOPHARMACOLOGY
- Cytokine Alterations in Schizophrenia: An Updated Review
- (2019) Sara Momtazmanesh et al. Frontiers in Psychiatry
- ABCB1 and DRD3 polymorphism as a response predicting biomarker and tool for pharmacogenetically guided clozapine dosing in Asian Indian treatment resistant schizophrenia patients
- (2019) Naveen M et al. Asian Journal of Psychiatry
- COMT and GAD1 gene polymorphisms are associated with impaired antisaccade task performance in schizophrenic patients
- (2018) Anna V. Kirenskaya et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Accessing Gene Expression in Treatment-Resistant Schizophrenia
- (2018) Patricia N. Moretti et al. MOLECULAR NEUROBIOLOGY
- Gene–gene interaction between DRD4 and COMT modulates clinical response to clozapine in treatment-resistant schizophrenia
- (2018) Veera M. Rajagopal et al. Pharmacogenetics and Genomics
- Haplotypic and Genotypic Association of Catechol-O-Methyltransferase rs4680 and rs4818 Polymorphisms and Treatment Resistance in Schizophrenia
- (2018) Marina Sagud et al. Frontiers in Pharmacology
- Short overview on metabolomic approach and redox changes in psychiatric disorders
- (2018) Gordana Nedic Erjavec et al. Redox Biology
- Carbonyl Stress and Microinflammation-Related Molecules as Potential Biomarkers in Schizophrenia
- (2018) Tohru Ohnuma et al. Frontiers in Psychiatry
- Treatment resistant schizophrenia: Clinical, biological, and therapeutic perspectives
- (2018) Frederick C. Nucifora et al. NEUROBIOLOGY OF DISEASE
- Biological Predictors of Clozapine Response: A Systematic Review
- (2018) Ruta Samanaite et al. Frontiers in Psychiatry
- Resistance is not futile: treatment-refractory schizophrenia – overview, evaluation and treatment
- (2018) Justin Faden et al. EXPERT OPINION ON PHARMACOTHERAPY
- Does relapse contribute to treatment resistance? Antipsychotic response in first- vs. second-episode schizophrenia
- (2018) Hiroyoshi Takeuchi et al. NEUROPSYCHOPHARMACOLOGY
- Stress Exposure in Dopamine D4 Receptor Knockout Mice Induces Schizophrenia-Like Behaviors via Disruption of GABAergic Transmission
- (2018) Tao Tan et al. SCHIZOPHRENIA BULLETIN
- C-reactive protein levels and treatment resistance in schizophrenia-A Danish population-based cohort study
- (2017) Henriette Thisted Horsdal et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Potential Role of Patients’ CYP3A-Status in Clozapine Pharmacokinetics
- (2017) Katalin Tóth et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Muscarinic receptor signaling contributes to atypical antipsychotic drug reversal of the phencyclidine-induced deficit in novel object recognition in rats
- (2017) Masanori Miyauchi et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Pyridoxamine: A novel treatment for schizophrenia with enhanced carbonyl stress
- (2017) Masanari Itokawa et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- The critical treatment window of clozapine in treatment-resistant schizophrenia: Secondary analysis of an observational study
- (2017) Bunta Yoshimura et al. PSYCHIATRY RESEARCH
- Shorter telomere length in people with schizophrenia: A preliminary study from Australia
- (2017) Cherrie Galletly et al. SCHIZOPHRENIA RESEARCH
- Putative presynaptic dopamine dysregulation in schizophrenia is supported by molecular evidence from post-mortem human midbrain
- (2017) T D Purves-Tyson et al. Translational Psychiatry
- GSTM1/GSTT1 double-null genotype increases risk of treatment-resistant schizophrenia: A genetic association study in Brazilian patients
- (2017) Denise S. Pinheiro et al. PLoS One
- Association between serum levels of glutamate and neurotrophic factors and response to clozapine treatment
- (2017) Amir Krivoy et al. SCHIZOPHRENIA RESEARCH
- Genetic association analysis of N-methyl-d-aspartate receptor subunit geneGRIN2Band clinical response to clozapine
- (2016) Danielle L. Taylor et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Detection and treatment of omega-3 fatty acid deficiency in psychiatric practice: Rationale and implementation
- (2016) Erik Messamore et al. Lipids in Health and Disease
- High-resolution copy number variation analysis of schizophrenia in Japan
- (2016) I Kushima et al. MOLECULAR PSYCHIATRY
- Preliminary evidence for association of genome-wide significant DRD2 schizophrenia risk variant with clozapine response
- (2016) Eric Huang et al. PHARMACOGENOMICS
- Treatment resistant schizophrenia is associated with the worst community functioning among severely-ill highly-disabling psychiatric conditions and is the most relevant predictor of poorer achievements in functional milestones
- (2016) Felice Iasevoli et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Is it time for immunopsychiatry in psychotic disorders?
- (2016) Marion Leboyer et al. PSYCHOPHARMACOLOGY
- The role of the ITIH3 rs2535629 variant in antipsychotic response
- (2016) E.J. Brandl et al. SCHIZOPHRENIA RESEARCH
- Peripheral Immune Cell Populations Associated with Cognitive Deficits and Negative Symptoms of Treatment-Resistant Schizophrenia
- (2016) Emilio Fernandez-Egea et al. PLoS One
- Neurodevelopmental Animal Models Reveal the Convergent Role of Neurotransmitter Systems, Inflammation, and Oxidative Stress as Biomarkers of Schizophrenia: Implications for Novel Drug Development
- (2015) M. Möller et al. ACS Chemical Neuroscience
- Drug repurposing and emerging adjunctive treatments for schizophrenia
- (2015) Jan Malte Bumb et al. EXPERT OPINION ON PHARMACOTHERAPY
- Advanced glycation end products and schizophrenia: A systematic review
- (2015) Youssef Kouidrat et al. JOURNAL OF PSYCHIATRIC RESEARCH
- The muscarinic system, cognition and schizophrenia
- (2015) Sean P. Carruthers et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Hypothalamic–pituitary–adrenal system, neurotrophic factors and clozapine response
- (2015) Marina Mitjans et al. Pharmacogenetics and Genomics
- COMT Val158Met and 5-HT1A-R -1019 C/G polymorphisms: effects on the negative symptom response to clozapine
- (2015) Marta Bosia et al. PHARMACOGENOMICS
- Increased rare duplication burden genomewide in patients with treatment-resistant schizophrenia
- (2015) A. K. Martin et al. PSYCHOLOGICAL MEDICINE
- High predictive value of immune-inflammatory biomarkers for schizophrenia diagnosis and association with treatment resistance
- (2015) Cristiano Noto et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Effects of oxidative stress on fatty acid- and one-carbon-metabolism in psychiatric and cardiovascular disease comorbidity
- (2014) J. Assies et al. ACTA PSYCHIATRICA SCANDINAVICA
- Synergistic association ofPI4KAandGRM3genetic polymorphisms with poor antipsychotic response in south Indian schizophrenia patients with low severity of illness
- (2014) Harpreet Kaur et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- PRSice: Polygenic Risk Score software
- (2014) Jack Euesden et al. BIOINFORMATICS
- Antipsychotic treatment modulates glutamate transport and NMDA receptor expression
- (2014) Mathias Zink et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Treatment-resistant schizophrenia and DAT and SERT polymorphisms
- (2014) Petar Bilic et al. GENE
- De novo mutations in schizophrenia implicate synaptic networks
- (2014) Menachem Fromer et al. NATURE
- A polygenic burden of rare disruptive mutations in schizophrenia
- (2014) Shaun M. Purcell et al. NATURE
- Pharmacogenetic associations of the type-3 metabotropic glutamate receptor (GRM3) gene with working memory and clinical symptom response to antipsychotics in first-episode schizophrenia
- (2014) Jeffrey R. Bishop et al. PSYCHOPHARMACOLOGY
- Significance of Measurements of Peripheral Carbonyl Stress Markers in a Cross-sectional and Longitudinal Study in Patients With Acute-stage Schizophrenia
- (2014) Narimasa Katsuta et al. SCHIZOPHRENIA BULLETIN
- Dopamine Synthesis Capacity in Patients With Treatment-Resistant Schizophrenia
- (2013) Arsime Demjaha et al. AMERICAN JOURNAL OF PSYCHIATRY
- Antipsychotic Treatment Resistance in Schizophrenia Associated with Elevated Glutamate Levels but Normal Dopamine Function
- (2013) Arsime Demjaha et al. BIOLOGICAL PSYCHIATRY
- Schizophrenie - eine milde Enzephalitis?
- (2013) K. Bechter FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE
- The social and economic burden of treatment-resistant schizophrenia
- (2013) James L. Kennedy et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Recurrent deletions of ULK4 in schizophrenia: a gene crucial for neuritogenesis and neuronal motility
- (2013) B. Lang et al. JOURNAL OF CELL SCIENCE
- Histamine H4 Receptor Polymorphism
- (2013) Zhiyun Wei et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Increases in triglyceride levels are associated with clinical response to clozapine treatment
- (2013) John Lally et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis
- (2013) LANCET
- The role of cannabinoid 1 receptor expressing interneurons in behavior
- (2013) Jacquelyn A. Brown et al. NEUROBIOLOGY OF DISEASE
- Plasma levels of mature brain-derived neurotrophic factor (BDNF) and matrix metalloproteinase-9 (MMP-9) in treatment-resistant schizophrenia treated with clozapine
- (2013) Hidenaga Yamamori et al. NEUROSCIENCE LETTERS
- The Endocannabinoid System and its Role in Schizophrenia: A Systematic Review of the Literature
- (2013) Rodrigo Ferretjans et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- Clinical Features of Schizophrenia With Enhanced Carbonyl Stress
- (2013) Mitsuhiro Miyashita et al. SCHIZOPHRENIA BULLETIN
- Cholinergic muscarinic M4 receptor gene polymorphisms: A potential risk factor and pharmacogenomic marker for schizophrenia
- (2013) Elizabeth Scarr et al. SCHIZOPHRENIA RESEARCH
- Meta-Analysis of Lymphocytes in Schizophrenia: Clinical Status and Antipsychotic Effects
- (2012) Brian J. Miller et al. BIOLOGICAL PSYCHIATRY
- Novel Allosteric Agonists of M1 Muscarinic Acetylcholine Receptors Induce Brain Region-Specific Responses That Correspond with Behavioral Effects in Animal Models
- (2012) G. J. Digby et al. JOURNAL OF NEUROSCIENCE
- Inflammatory markers in antipsychotic-naïve patients with nonaffective psychosis and deficit vs. nondeficit features
- (2012) Clemente Garcia-Rizo et al. PSYCHIATRY RESEARCH
- Outcome definitions and clinical predictors influence pharmacogenetic associations between HTR3A gene polymorphisms and response to clozapine in patients with schizophrenia
- (2012) A. P. Rajkumar et al. PSYCHOPHARMACOLOGY
- DRD1 rs4532 polymorphism: A potential pharmacogenomic marker for treatment response to antipsychotic drugs
- (2012) Vanessa Kiyomi Ota et al. SCHIZOPHRENIA RESEARCH
- Cognitive impairment is related to oxidative stress and chemokine levels in first psychotic episodes
- (2012) Mónica Martínez-Cengotitabengoa et al. SCHIZOPHRENIA RESEARCH
- Human Copy Number Variation and Complex Genetic Disease
- (2011) Santhosh Girirajan et al. Annual Review of Genetics
- Association between type-three metabotropic glutamate receptor gene (GRM3) variants and symptom presentation in treatment refractory schizophrenia
- (2011) Jeffrey R. Bishop et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment
- (2011) Bita Moghaddam et al. NEUROPSYCHOPHARMACOLOGY
- Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression
- (2011) Brian Leonard et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Glutamate signaling in the pathophysiology and therapy of schizophrenia
- (2011) Chieh-Hsin Lin et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Dopamine D4 and D5 receptor gene variant effects on clozapine response in schizophrenia: Replication and exploration
- (2011) Rudi Hwang et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Involvement of histamine receptors in the atypical antipsychotic profile of clozapine: a reassessment in vitro and in vivo
- (2011) Marie Humbert-Claude et al. PSYCHOPHARMACOLOGY
- Akt1 deficiency in schizophrenia and impairment of hippocampal plasticity and function
- (2010) Darrick T. Balu et al. HIPPOCAMPUS
- Influence of serotonin transporter gene polymorphisms on clozapine response in Brazilian schizophrenics
- (2010) Fabiana B. Kohlrausch et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Oxidative stress in schizophrenia: An integrated approach
- (2010) Byron K.Y. Bitanihirwe et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Naturalistic pharmacogenetic study of treatment resistance to typical neuroleptics in European–Brazilian schizophrenics
- (2010) Fabiana B. Kohlrausch et al. Pharmacogenetics and Genomics
- Influence of serotonin 3A and 3B receptor genes on clozapine treatment response in schizophrenia
- (2010) Renan P. Souza et al. Pharmacogenetics and Genomics
- Brain Cannabinoid CB2 Receptor in Schizophrenia
- (2009) Hiroki Ishiguro et al. BIOLOGICAL PSYCHIATRY
- Clozapine, GABAB, and the Treatment of Resistant Schizophrenia
- (2009) Z J Daskalakis et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Mechanisms of Action of Antipsychotic Drugs of Different Classes, Refractoriness to Therapeutic Effects of Classical Neuroleptics, and Individual Variation in Sensitivity to their Actions: PART I
- (2009) R. Miller Current Neuropharmacology
- Redox dysregulation, neurodevelopment, and schizophrenia
- (2009) Kim Q Do et al. CURRENT OPINION IN NEUROBIOLOGY
- Cerebrospinal fluid analysis in affective and schizophrenic spectrum disorders: Identification of subgroups with immune responses and blood–CSF barrier dysfunction
- (2009) K. Bechter et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics
- (2009) J L McClay et al. MOLECULAR PSYCHIATRY
- Effect of dopamine D3 receptor gene polymorphisms and clozapine treatment response: exploratory analysis of nine polymorphisms and meta-analysis of the Ser9Gly variant
- (2009) R Hwang et al. PHARMACOGENOMICS JOURNAL
- Role of cannabis and endocannabinoids in the genesis of schizophrenia
- (2009) Emilio Fernandez-Espejo et al. PSYCHOPHARMACOLOGY
- Rare chromosomal deletions and duplications increase risk of schizophrenia
- (2008) Jennifer L. Stone et al. NATURE
- Relationship between three serotonin receptor subtypes (HTR3A, HTR2A and HTR4) and treatment-resistant schizophrenia in the Japanese population
- (2008) Xiaofei Ji et al. NEUROSCIENCE LETTERS
- Contribution of the Functional 5-HTTLPR Variant of the SLC6A4 Gene to Obesity Risk in Male Adults
- (2008) Silvia Sookoian et al. Obesity
- The CNR1 gene as a pharmacogenetic factor for antipsychotics rather than a susceptibility gene for schizophrenia
- (2007) Nora Hamdani et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now